These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.
    Author: Fett NM, Fiorentino D, Werth VP.
    Journal: Dermatol Clin; 2016 Jul; 34(3):243-50. PubMed ID: 27363879.
    Abstract:
    Patients with skin-predominant lupus erythematosus, dermatomyositis, and morphea should be evaluated, treated, and followed by dermatologists who can take primary responsibility for their care. Many academic centers have specialized centers with dermatologists who care for these patients. Patients with skin-predominant lupus erythematosus should be followed regularly with laboratory tests to detect significant systemic disease. Antibody tests can help determine the risks for individual patients. Patients with morphea rarely progress to systemic disease, but therapies can be helpful in treating and preventing progression of disease.
    [Abstract] [Full Text] [Related] [New Search]